Search
for
Sort by
Research 30 of 1000+
- Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis
- 1495 Dimethyl fumarate ameliorates delayed wound healing due to IL-36Ra deficiency through inhibition of NET formation and oxidative stress
- “Nail loss after teriflunomide treatment: A new potential adverse event”
- BH25 Alopecia in a patient undergoing multiple treatments for multiple sclerosis: a rare presentation and case review
- Treating Psoriasis: What Is New About Fumaric Acid Esters?
- Editors' Picks
- Dermatological drugs, topical agents, and cosmetics
- The Shifting Landscape of Disease-Modifying Therapies for Relapsing Multiple Sclerosis
- Where it all went right
- Clinical Snippets
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Skin Penetration and Permeation Properties of Transcutol® in Complex Formulations
- Teriflunomide in multiple sclerosis: an update
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice?
- Dermatological medications and local therapeutics
- Comparative gene expression analysis of nestin-expressing hair follicle-derived cells
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- Hair Loss Associated with Teriflunomide Treatment
- General Dermatology
- Scalable production of controllable dermal papilla spheroids on PVA surfaces and the effects of spheroid size on hair follicle regeneration
- Glutamine Metabolism Controls Stem Cell Fate Reversibility and Long-Term Maintenance in the Hair Follicle
- Do Dermatoses Trigger Neurodegenerative Diseases? A Retrospective Observational Study
- Case of alemtuzumab-related alopecia areata management in MS
- Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis
- CuATSM Enhances Wound Repair Without Scarring via Hippo/YAP Signalling Pathway to Reduce Ferroptosis and Macrophage Polarisation
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Macrophage Related Chronic Inflammation in Non-Healing Wounds
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Thou shall not heal: Overcoming the non-healing behaviour of diabetic foot ulcers by engineering the inflammatory microenvironment